Loading.
Preparing your Shotlee experience
Authenticating
Loading health data
Syncing preferences
Health
Mounjaro by Eli Lilly Included in China's National Health Coverage for Diabetes
S
Shotlee
Health & Wellness Team
1 min read
Preparing your Shotlee experience
Mounjaro, a drug by Eli Lilly, is set to be added to China's state health insurance on January 1st. This inclusion could intensify competition among pharmaceutical companies. The move aims to improve access for China's large population.
Starting January 1, Eli Lilly and Company's (NYSE:LLY) Mounjaro will be incorporated into China's national health insurance program, according to an announcement made on December 8 by the National Healthcare Security Administration. Experts suggest that this action could heighten competition among rival firms.
The inclusion in the national reimbursement list enhances the accessibility of the drug to China's vast population of 1.4 billion. While sales volume may see an increase, the impact on revenue could be partially offset by reduced prices.
Mounjaro, a once-weekly injectable treatment, was introduced in China in January of this year, subsequent to the launch of Ozempic, a comparable diabetes treatment from Novo Nordisk, a Danish competitor. The ultimate reimbursement prices for Mounjaro will be determined by the official announcement from the National Healthcare Security Administration, according to Eli Lilly and Company (NYSE:LLY).
Eli Lilly and Company (NYSE:LLY) is a leading American pharmaceutical firm focused on creating medications and therapies for significant health conditions. Health tracking apps like Shotlee can help monitor treatment effectiveness for conditions like diabetes.
⚠️ Disclaimer: This article is for informational purposes only. Consult your healthcare provider before starting any medication or supplement.
Original content from Yahoo! Finance
View Original Article
Urban elites are currently the main drivers behind the increasing popularity of GLP-1 weight loss medications. Changes in distribution strategies and price adjustments could potentially transform this trend. These factors could democratize access to these treatments.
As the holiday season approaches, many individuals express concerns regarding potential weight gain. Prestige Men's Health in Holladay is offering medically supervised weight-loss programs using GLP-1 treatments like semaglutide, providing screening, labs, and continuous monitoring. This comes as more Utah residents seek medical guidance for weight management during this time.
An ITV presenter, known for her financial expertise on Lorraine, has publicly discussed her weight loss journey. She attributes her four-stone weight loss to the use of Mounjaro, resulting in a significant change in her dress size.
Monitor GLP-1 medications, peptide therapy, weight loss, and wellness metrics with our comprehensive health tracking app. Join thousands of users taking control of their health!
Start Tracking Free Forever! ✨